GHK-CU 50mg

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

GHK-Cu is a naturally-occurring copper tripeptide — glycyl-L-histidyl-L-lysine bound to copper(II) — that the body produces and that declines with age[1][2]. It is reported to take part in tissue remodeling, collagen and elastin synthesis, wound repair and antioxidant defense. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. Almost all of GHK-Cu’s evidence is topical, in-vitro or animal; there are no completed controlled human trials of injectable GHK-Cu, and injectable GHK-Cu is an unapproved research chemical — presented for research and educational use only.

Add 3.0 mL bacteriostatic water to one 50 mg vial → ~16.67 mg/mL, a concentration that keeps small doses on readable U-100 marks.
1.0–2.0 mg per injection, started low and titrated upward; most reference patterns use 5 days/week or 3×/week.
At ~16.67 mg/mL, 1 unit ≈ 0.167 mg; 1 mg ≈ 6 units and 2 mg ≈ 12 units on a U-100 syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate dosing, step by step

Standard / Conservative Approach (3 mL = ~16.67 mg/mL; 5 days/week)

Phase / Week(s)	Dose	Volume (U-100 units / mL)
Weeks 1–4	1.0 mg (1000 mcg)	6 units (0.06 mL)
Weeks 5–8	1.5 mg (1500 mcg)	9 units (0.09 mL)
Weeks 9–12+	2.0 mg (2000 mcg)	12 units (0.12 mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 50 mg vial → final concentration ~16.67 mg/mL (16,670 mcg/mL).
Typical range: 1.0–2.0 mg per injection, raised gradually over an 8–12 week course; start low to gauge tolerance.
Easy measuring: At ~16.67 mg/mL, 1 unit ≈ 0.167 mg on a U-100 syringe. For doses of 10 units or less, a 30- or 50-unit insulin syringe improves readability.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Frequency: one subcutaneous injection 5 days per week, titrating up as tolerated[5][6]. This gradual titration lets you assess individual tolerance while keeping injection volumes practical. These figures come from reference patterns, not from approved human dosing.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

Alternative Approach (3 mL = ~16.67 mg/mL; 3× weekly)

Phase / Week(s)	Dose	Volume (U-100 units / mL)
Weeks 1–12+	2.0 mg (2000 mcg)	12 units (0.12 mL)

Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until the deep-blue solution is fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
Frequency: Inject 2 mg three times per week (e.g., Monday / Wednesday / Friday)[6]. This maintains a steady weekly total of about 6 mg with fewer injections.
Reconstituted GHK-Cu is an intense blue from the copper-peptide complex; this is expected. Avoid freezing the mixed solution, since freeze–thaw can degrade the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume an 8–16 week course; figures are shown for both 5 days/week and 3×/week patterns.

A 50 mg vial covers several weeks of dosing, so most courses need only 1–3 vials.
5 days/week (~1–2 mg/day): ~1–3 vials
3×/week (2 mg): ~1–2 vials
16 weeks: ~3 vials
Per injection: 1 syringe
8 weeks (5 days/week): ~40 syringes
16 weeks (5 days/week): ~80 syringes
Use ~3.0 mL per 50 mg vial for reconstitution.
1–2 vials: ~3–6 mL → 1 bottle
3 vials: ~9 mL → 1 bottle
One for the vial stopper + one for the injection site each time.
Per injection: 2 swabs
8 weeks (5 days/week): ~80 swabs → 1 box

Protocol Overview

A concise summary of the regimen, drawn from commonly cited reference patterns for GHK-Cu.

▪Goal: Support skin remodeling, collagen/elastin synthesis and tissue repair via the copper tripeptide — effects reported mainly from topical, in-vitro and animal work, not established in humans by injection[3][5].
▪Schedule: Subcutaneous injections 5 days per week (or 3×/week) for 8–12 weeks, optionally extended to ~16 weeks.
▪Dose Range: 1.0–2.0 mg per injection with gradual titration.
▪Reconstitution: 3.0 mL bacteriostatic water per 50 mg GHK-Cu vial gives ~16.67 mg/mL for accurate unit measurements.
▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested titration approach based on common reference doses for GHK-Cu.

▪Start: Begin at 1.0 mg per injection to gauge tolerability.
▪Titrate: Increase by roughly 0.5 mg every four weeks as tolerated.
▪Target: Reach about 1.5–2.0 mg per injection by weeks 5–12.
▪Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
▪Timing: Inject at a consistent time and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the copper peptide’s stability and activity.

▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 30 days; do not freeze the mixed solution, as freezing can degrade peptides[8].
▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the deep-blue solution clear of heat and direct light.
▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.

Important Notes

Practical points that keep administration safe and consistent.

▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
▪Recordkeeping: Log the dose, injection site and any observations to keep the protocol consistent.
▪Regulatory note: Injectable GHK-Cu is not FDA-approved for human administration and is sold only as a research chemical[10].

How This Works

GHK-Cu is a naturally-occurring copper tripeptide — the sequence glycyl-L-histidyl-L-lysine (GHK) bound to a copper(II) ion. It occurs in human plasma, saliva and urine, and its levels decline with age[1][2]. GHK has a high affinity for copper and acts as a carrier that helps shuttle copper into cells.

In laboratory and animal studies, GHK-Cu is reported to stimulate collagen and elastin synthesis, support wound healing and angiogenesis, act as an antioxidant and anti-inflammatory, and modulate the expression of genes tied to skin repair and tissue remodeling[3][4][5]. These are the mechanisms most often cited for its cosmetic use.
It is important to be clear about where the evidence comes from: GHK-Cu is used overwhelmingly topically in cosmetics, where most of its human data — small studies of creams and serums for skin firmness, fine lines and wound repair — actually lies[6]. The collagen, anti-aging and healing claims rest largely on topical, in-vitro and animal data.
Important caveat: there are no completed controlled human clinical trials of injectable or systemic GHK-Cu. The systemic (subcutaneous) use described here is unproven and unapproved — benefits seen with topical or in-vitro GHK-Cu should not be assumed to transfer to injection, and the safety of injected copper-peptide is not established.
Injectable GHK-Cu is not an approved medicine. It is an unapproved research chemical presented here for research and educational purposes only.

Lifestyle Factors

Habits that may support skin and tissue health alongside the protocol.

▪Nutrition: Keep protein and micronutrient intake adequate to give collagen and tissue repair the building blocks they need.
▪Sun protection: Daily SPF and UV avoidance limit the photo-damage that GHK-Cu is most often used to address.
▪Sleep: Aim for 7–9 hours to support the body’s natural repair processes.
▪Stress: Manage stress with evidence-based practices, since it influences skin and overall healing.

Potential Benefits & Side Effects

What topical, in-vitro and animal literature describe; human evidence is largely topical and injectable use is unproven.

▪Skin remodeling (topical/in-vitro): GHK-Cu is reported to boost collagen and elastin and improve skin firmness in topical and cell studies[3][6].
▪Wound healing & antioxidant (preclinical): Animal and lab work links GHK-Cu to faster wound repair, angiogenesis and antioxidant activity[4][5].
▪Gene modulation (in-vitro): GHK-Cu has been reported to shift the expression of many genes toward tissue repair in cultured cells[5].
▪Note on injection: These benefits are not established for injected GHK-Cu in humans — no controlled clinical trials of systemic GHK-Cu have been completed[11].
▪Injection-site reactions: Mild redness, tenderness or transient blue discolouration at the site can occur; rotating sites helps.
▪Copper exposure: Because the molecule delivers copper, the long-term effect of repeated systemic copper-peptide dosing is unknown; caution and monitoring are advised.
▪Unknown human safety: Injectable GHK-Cu has no completed human safety data, so treat it as experimental.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[12][13].

▪Wash your hands well with soap and water.
▪Wipe the vial stopper with an alcohol swab and let it air-dry.
▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[13].
▪Draw the intended dose, then check for air bubbles and push any out.
▪Pinch a skinfold at the chosen site between thumb and forefinger.
▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[12].
▪Skip aspiration for subcutaneous shots — it isn’t needed[12].
▪Press the plunger slowly and steadily until it’s fully down.
▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
▪Return the reconstituted vial to the fridge right away.
▪Rotate the injection site each time to prevent irritation and lipohypertrophy[9].
▪Watch the site for excess redness, swelling, or signs of infection.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides for GHK-Cu (50 mg).

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA. Open source
▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Prime Lab Peptides →

References

Reference-derived details for GHK-CU 50mg.

GHK-Cu (50mg Vial) Dosage Protocol Open source
1 Cosmetics / MDPI (PubMed) GHK and GHK-Cu: the human copper tripeptide, its decline with age and roles in tissue remodeling. View Source ↗ Open source
2 BioMed Research International (PubMed) GHK-Cu chemistry: glycyl-L-histidyl-L-lysine copper complex and copper transport. View Source ↗ Open source
3 International Journal of Molecular Sciences (PubMed) GHK-Cu stimulation of collagen, elastin and dermal matrix synthesis in skin models. View Source ↗ Open source
4 Journal of Aging Research (PubMed) GHK-Cu antioxidant, anti-inflammatory and wound-healing activity in preclinical models. View Source ↗ Open source
5 Gene expression analysis (PubMed) GHK-mediated modulation of gene expression toward tissue repair in cultured human cells. View Source ↗ Open source
6 Clinical / topical cosmetic studies (PubMed) Topical copper-peptide trials for skin firmness, fine lines and photoaging — the bulk of human GHK-Cu evidence. View Source ↗ Open source
7 Peptide Storage Guide Best practices for storing lyophilized peptides (temperature, humidity and light protection). View Source ↗ Open source
8 Bacteriostatic Water Guidance Bacteriostatic water for injection: multi-dose vial stability and handling. View Source ↗ Open source
9 NCBI Bookshelf Best practices for subcutaneous injection: aseptic technique and site rotation. View Source ↗ Open source
10 U.S. Food & Drug Administration GHK-Cu is not an FDA-approved drug for injection; injectable copper-peptide is sold as a research chemical. View Source ↗ Open source
11 ClinicalTrials.gov Trial registry search for GHK / copper-peptide; no completed efficacy trials of injectable systemic GHK-Cu. View Source ↗ Open source
12 Centers for Disease Control and Prevention (CDC) Subcutaneous injection technique: angle, site and no-aspiration guidance. View Source ↗ Open source
13 Subcutaneous Injection Technique (Patient Education) How to administer a subcutaneous injection: clinical technique guidelines. View Source ↗ Open source
14 Prime Lab Peptides GHK-Cu (50 mg) product page — purity specifications and certificates of analysis. View Source ↗ Open source

Contents